GMAB ▲ +11.0% - Genmab A/S $GMAB Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma 05-OCT-2026 02:50 PM ET